Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study to Learn About The Study Medicine (PF-07038124) In Patients With Mild To Moderate Atopic Dermatitis Or Mild To Severe Plaque Psoriasis.

ClinicalTrials.gov ID: NCT05375955

Public ClinicalTrials.gov record NCT05375955. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 16, 2026, 9:31 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A PHASE 2B, RANDOMIZED, DOUBLE BLIND, VEHICLE CONTROLLED, PARALLEL GROUP STUDY TO ASSESS THE EFFICACY, SAFETY, TOLERABILITY AND PHARMACOKINETICS OF MULTIPLE DOSE LEVELS OF PF-07038124 OINTMENT FOR 12 WEEKS IN PARTICIPANTS 12 YEARS AND OLDER AND WITH MILD-TO-MODERATE ATOPIC DERMATITIS OR MILD-TO-SEVERE PLAQUE PSORIASIS

Study identification

NCT ID
NCT05375955
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Pfizer
Industry
Enrollment
263 participants

Conditions and interventions

Interventions

  • PF-07038124 ointment 0.01% Drug
  • PF-07038124 ointment 0.03% Drug
  • PF-07038124 ointment 0.06% Drug
  • Vehicle ointment Drug

Drug

Eligibility (public fields only)

Age range
12 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 25, 2022
Primary completion
Jul 30, 2023
Completion
Jul 30, 2023
Last update posted
Oct 1, 2024

2022 – 2023

United States locations

U.S. sites
23
U.S. states
14
U.S. cities
20
Facility City State ZIP Site status
California Dermatology & Clinical Research Institute Encinitas California 92024
USC/Norris Comprehensive Cancer Center Los Angeles California 90033
Renaissance Research and Medical Group Cape Coral Florida 33991
Clinical Neuroscience Solutions, Inc. dba CNS Healthcare Jacksonville Florida 32256
ForCare Clinical Research Tampa Florida 33613
Skin Care Physicians of Georgia Macon Georgia 31217
Sneeze, Wheeze & Itch Associates, LLC Normal Illinois 61761
Dawes Fretzin Clinical Research Group, LLC Indianapolis Indiana 46250
Velocity Clinical Research at The Dermatology Clinic, Baton Rouge Baton Rouge Louisiana 70808
University of Michigan Ann Arbor Michigan 48109
Wayne Health Dearborn Michigan 48124
Northwell Health Clinical Trials Office Lake Success New York 11042
Icahn School of Medicine at Mount Sinai New York New York 10028
Icahn School of Medicine at Mount Sinai New York New York 10029
Vital Prospects Clinical Research Institute, PC Tulsa Oklahoma 74136
Velocity Clinical Research, Medford Medford Oregon 97504
Health Concepts Rapid City South Dakota 57702
Clinical Neuroscience Solutions Inc. Memphis Tennessee 38119
Clinical Neuroscience Solutions, Inc. dba CNS Healthcare Memphis Tennessee 38119
Dermatology Treatment and Research Center Dallas Texas 75230
Progressive Clinical Research San Antonio Texas 78213
Texas Dermatology and Laser Specialists San Antonio Texas 78218
Virginia Clinical Research, Inc. Norfolk Virginia 23502

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 16 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05375955, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 1, 2024 · Synced May 16, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05375955 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →